COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry

BACKGROUND AND OBJECTIVE: To describe the impact of coronavirus disease 2019 (COVID-19) on people with neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody disease (MOGAD). METHODS: The COVID-19 Infections in Multiple Sclerosis (MS) and Related Diseases (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Newsome, Scott D., Cross, Anne H., Fox, Robert J., Halper, June, Kanellis, Pamela, Bebo, Bruce, Li, David, Cutter, Gary R., Rammohan, Kottil W., Salter, Amber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407145/
https://www.ncbi.nlm.nih.gov/pubmed/34429342
http://dx.doi.org/10.1212/NXI.0000000000001057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407145/
https://www.ncbi.nlm.nih.gov/pubmed/34429342
http://dx.doi.org/10.1212/NXI.0000000000001057

Ejemplares similares